Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ERIBULIN vs ERTUGLIFLOZIN PIDOLATE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ERIBULIN vs ERTUGLIFLOZIN PIDOLATE: Safety Overview

Metric ERIBULIN ERTUGLIFLOZIN PIDOLATE
Total FAERS Reports 5,055 681
Deaths Reported 793 4
Death Rate 15.7% 0.6%
Hospitalizations 2,642 128
Average Patient Age 57.3 yrs 57.0 yrs
% Female Patients 93.0% 56.1%
FDA Approval Date Apr 5, 2024 N/A
Manufacturer Gland Pharma Limited Merck Sharp & Dohme LLC
Route INTRAVENOUS ORAL
Marketing Status Prescription N/A